In an ongoing development in the opioid litigation, Express Scripts Inc., the pharmaceutical benefit manager, has now become the second defendant to seek disqualification of Motley Rice from several opioid lawsuits. This move, fuelled by what the defendant refers to as “newly discovered evidence”, was made clear in a brief filed on March 13 which referenced a subpoena issued by Linda Singer, a Motley Rice member, to Express Scripts on behalf of the City of Chicago.
Express Scripts, currently facing impending bellwether trials concerning the opioid crisis, argues that this subpoena – originating from a period when Singer was affiliated with Cohen Milstein Sellers & Toll – presents a conflict of interests. This claim adds to the mounting pressure on Motley Rice, who now finds themselves under scrutiny from multiple fronts within the complex opioid litigation landscape.
For further details on the matter, please refer to the original reporting on Law.com.